Conference Coverage

VIDEO: Advanced alternative payment model for RA set to undergo testing

Publish date: November 20, 2017

 

AT ACR 2017

Dr. Huston, Dr. Worthing, and Dr. Laing had no relevant conflicts of interest to disclose.

Pages

Recommended Reading

Biosimilars poised to save $54 billion over the next decade
MDedge Rheumatology
In close vote, advisory panel prefers Shingrix over Zostavax
MDedge Rheumatology
“Great debates” at ACR 2017 address biosimilar switching, new curricular milestones
MDedge Rheumatology
Precision medicine’s future in rheumatic diseases outlined at ACR 2017
MDedge Rheumatology
New RA JAK inhibitor, monoclonal antibody trial results scheduled for ACR 2017
MDedge Rheumatology
VIDEO: Biologic use during pregnancy had no impact on serious infection risks in infants
MDedge Rheumatology
Methotrexate holiday linked to better flu vaccine immunogenicity
MDedge Rheumatology
Obesity linked to RA disease activity, disability
MDedge Rheumatology
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Rheumatology
Blindness linked to HCQ use rare in rheumatic patients
MDedge Rheumatology